NDC 71334-215

Pyrukynd

Mitapivat

Pyrukynd is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Agios Pharmaceuticals, Inc.. The primary component is Mitapivat.

Product ID71334-215_4f7f30de-6e7c-47b5-910b-d37f95140ead
NDC71334-215
Product TypeHuman Prescription Drug
Proprietary NamePyrukynd
Generic NameMitapivat
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2022-02-18
Marketing CategoryNDA /
Application NumberNDA216196
Labeler NameAgios Pharmaceuticals, Inc.
Substance NameMITAPIVAT
Active Ingredient Strength50 mg/1
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 71334-215-50

4 BLISTER PACK in 1 CARTON (71334-215-50) > 14 TABLET, FILM COATED in 1 BLISTER PACK (71334-215-14)
Marketing Start Date2022-02-18
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Pyrukynd" or generic name "Mitapivat"

NDCBrand NameGeneric Name
71334-205Pyrukyndmitapivat
71334-210Pyrukyndmitapivat
71334-215Pyrukyndmitapivat
71334-220Pyrukyndmitapivat
71334-225Pyrukyndmitapivat
71334-230Pyrukyndmitapivat

Trademark Results [Pyrukynd]

Mark Image

Registration | Serial
Company
Trademark
Application Date
PYRUKYND
PYRUKYND
90768981 not registered Live/Pending
Agios Pharmaceuticals, Inc.
2021-06-11
PYRUKYND
PYRUKYND
90768935 not registered Live/Pending
Agios Pharmaceuticals, Inc.
2021-06-11
PYRUKYND
PYRUKYND
90768907 not registered Live/Pending
Agios Pharmaceuticals, Inc.
2021-06-11
PYRUKYND
PYRUKYND
88514664 not registered Live/Pending
Agios Pharmaceuticals, Inc.
2019-07-15

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.